(INSERM (Institut national de la santé et de la recherche médicale)) French medical researchers from the AP-HP (Henri Mondor Hospital and Avicenne Hospital) and Inserm (Unit 738 "Models and methods for therapeutic evaluation of chronic illnesses" and CIC 202, at Tours) have recently demonstrated the effectiveness of a new molecule in the fight against lice. Faced with the emergence of increasing resistance to conventional treatments by these parasites, this new medication represents a real therapeutic alternative which is effective in 95 percent of cases.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Medicine
- Smoking, Green Tea Consumption, Genetic Polymorphisms in the Insulin-Like Growth Factors and Lung Cancer Risk
- Differences in Acinetobacter baumannii Strains and Host Innate Immune Response Determine Morbidity and Mortality in Experimental
- Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types
- Two-Item Sentence Comprehension by a Dog (Canis familiaris)
- Risks of pregnancy via egg donation similar for women over age 50 as for younger women